PremiumCompany AnnouncementsIceCure Medical Reports Growth and Awaits FDA Decision IceCure Medical Ltd’s Earnings Call: Growth Amidst Challenges IceCure Medical Sees 42% Growth in ProSense® Sales Amid Awaited FDA Decision PremiumCompany AnnouncementsIceCure Medical Expands Global Patent Portfolio with New Cryogenic Pump Approval in China IceCure Medical receives Notice of Allowance from CNIPA IceCure Medical’s Cryoablation Shows Higher Patient Satisfaction in Japan Study PremiumCompany AnnouncementsIceCure Medical Seeks to Expand in China with ProSense® Cryoablation System IceCure Medical files for approval of ProSense Cryoablation System in China Icecure Medical Announces Equity Distribution Agreement